Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MAIA Biotechnology, Inc. (MAIA)
NYSE MKT:MAIA
MAIA Biotechnology, Inc. (MAIA) Stock Price & Analysis
74 Followers
MAIA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.82 - $4.25
Previous Close$2.04
Volume206.57K
Average Volume (3M)398.13K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-1.4
Beta0.63
Next Earnings
May 06, 2024EPS Estimate
-$0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.45
Shares Outstanding20,002,826
10 Day Avg. Volume205,987
30 Day Avg. Volume398,131
Standard Deviation0.27
R-Squared0.00699
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)92.37
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$14.00Price Target Upside586.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
MAIA Biotechnology, Inc. News
PremiumCompany Announcements
MAIA Biotechnology Boosts CEO Jeffrey Himmelreich’s Salary
PremiumCompany Announcements
MAIA Biotechnology at Risk of NYSE Delisting Over Equity Shortfalls
PremiumPre-Earnings
Is MAIA a Buy, Before Earnings?
MAIA FAQ
What was MAIA Biotechnology, Inc.’s price range in the past 12 months?
MAIA Biotechnology, Inc. lowest stock price was $0.82 and its highest was $4.25 in the past 12 months.
What is MAIA Biotechnology, Inc.’s market cap?
Currently, no data Available
When is MAIA Biotechnology, Inc.’s upcoming earnings report date?
MAIA Biotechnology, Inc.’s upcoming earnings report date is May 06, 2024 which is in 16 days.
How were MAIA Biotechnology, Inc.’s earnings last quarter?
MAIA Biotechnology, Inc. released its earnings results on Mar 22, 2024. The company reported -$0.39 earnings per share for the quarter, the consensus estimate of -$0.39 by $0.
Is MAIA Biotechnology, Inc. overvalued?
According to Wall Street analysts MAIA Biotechnology, Inc.’s price is currently Undervalued.
Does MAIA Biotechnology, Inc. pay dividends?
MAIA Biotechnology, Inc. does not currently pay dividends.
What is MAIA Biotechnology, Inc.’s EPS estimate?
MAIA Biotechnology, Inc.’s EPS estimate is -$0.39.
How many shares outstanding does MAIA Biotechnology, Inc. have?
MAIA Biotechnology, Inc. has 20,002,827 shares outstanding.
What happened to MAIA Biotechnology, Inc.’s price movement after its last earnings report?
MAIA Biotechnology, Inc. reported an EPS of -$0.39 in its last earnings report, expectations of -$0.39. Following the earnings report the stock price went up 8.763%.
Which hedge fund is a major shareholder of MAIA Biotechnology, Inc.?
Currently, no hedge funds are holding shares in MAIA
---
MAIA Biotechnology, Inc. Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.00 (586.27% Upside)
$14.00 (586.27% Upside)
Blogger Sentiment
Bullish
MAIA Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $40.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 7.0%
Last 30 Days ▲ 7.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-40.08%
12-Months-Change
Fundamentals
Return on Equity
-440.12%
Trailing 12-Months
Asset Growth
-37.06%
Trailing 12-Months
Company Description
MAIA Biotechnology, Inc.
MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
---
MAIA Stock 12 Months Forecast
Average Price Target
$14.00
▲(586.27% Upside)
Technical Analysis
Best Analysts Covering MAIA
1 Year
1 Year Success Rate
4/8 ratings generated profit
1 Year Average Return
-12.03%
reiterated a buy rating last month
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -12.03% per trade.
---